Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Torrent Pharmaceuticals has informed that ICRA has re-affirmed the credit rating and has revised the outlook as detailed attached. The rating letters issued by ICRA are also enclosed.
The above information is a part of company’s filings submitted to BSE.